Application 761041

Type: BLA
Sponsor: GENENTECH INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	TECENTRIQ	ATEZOLIZUMAB	INJECTABLE; INJECTION	1200MG/20ML	No	No

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TECENTRIQ	ATEZOLIZUMAB	Genentech, Inc.	6fa682c9-a312-4932-9831-f286908660ee	2026-05-20	Warnings, Adverse reactions	Exact identifier ndc (product): 50242-918

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 1 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
50242-918	TECENTRIQ	atezolizumab	Genentech, Inc.	BLA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
46566	ORIG	2016-12-27
46565	ORIG	2016-12-27
45959	ORIG	2016-11-28
45632	ORIG	2016-10-20
45626	ORIG	2016-10-18